Protocol to develop A 3D tumor model for drug testing applications
Three-dimensional (3D) tumor models provide physiologically relevant tumor environments and have become a major tool in cancer research and drug discovery. This article presents a protocol for creating a 3D organotypic tumor model by embedding a cancer cell spheroid within a collagen matrix containi...
Saved in:
Main Authors: | Prasiddha Guragain, Sunil Singh, Hossein Tavana |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | SLAS Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2472555224000686 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term live-cell imaging of GFAP+ astroglia and laminin+ vessels in organotypic mouse brain slices using microcontact printing
by: Christian Humpel
Published: (2025-01-01) -
A polysaccharide-based hydrogel platform for tumor spheroid production and anticancer drug screening
by: Elliot Lopez-Vince, et al.
Published: (2025-02-01) -
Exosome-like nanovesicles derived from kale juice enhance collagen production by downregulating Smad7 in human skin fibroblasts
by: Peihan Hsu, et al.
Published: (2025-02-01) -
The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration
by: Chiara Cencioni, et al.
Published: (2025-01-01) -
Cost-reduction strategy to culture patient derived bladder tumor organoids
by: Mahsa Mollapour Sisakht, et al.
Published: (2025-02-01)